PTC Therapeutics | PTCT - Passifs Courants





Passifs Courants Changement Date
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
Amgen USD 24.96B 534M 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Biogen USD 3B 350.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Cytokinetics USD 199.18M 3.27M 2026-03
Daiichi Sankyo JPY 778.55B 77.51B 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
Esperion Therapeutics USD 300.36M 451K 2026-03
Gilead Sciences USD 9.48B 2.34B 2026-03
Incyte USD 1.49B 25.52M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Ironwood Pharmaceuticals USD 236.31M 5.91M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Pfizer USD 34.35B 2.64B 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Puma Biotechnology USD 82.73M 3.63M 2025-09
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
TG Therapeutics USD 187.11M 33.35M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xencor USD 73.46M 22.45M 2026-03